A meeting of the Board of Directors of GlaxoSmithKline Pharmaceuticals Limited will be held on February 9, 2026, to consider and approve the unaudited financial results for the third quarter and nine months ended December 31, 2025. The meeting will address the financial performance of the company for Q3 2025.
Board Meeting Announcement
GlaxoSmithKline Pharmaceuticals Limited has announced a meeting of its Board of Directors to be held on February 9, 2026.
Agenda
The primary agenda of the board meeting is to review, approve, and record the unaudited financial results for the third quarter (Q3: October-December) and the nine-month period ending December 31, 2025.
Source: BSE
